Meet the team.

Our Team

Professor Phil Cowen 
Lead Clinical Psychiatrist & Professor of Psychopharmacology 

My research focuses on the psychopharmacology of depression. I am interested in the biochemical changes that are associated with depression and how drugs work to alleviate the symptoms that depressed patients experience. 

Dr Beata Godlewska
Honorary Consultant Psychiatrist & OxIMP Study Lead Researcher

My research focuses on two main areas: the psychopharmacology of mood disorders - depression and bipolar disorder - and psychological mechanisms of antidepressant drug action. I am primarily involved in assessing participants at the screening stage, and providing medical review throughout the study.

Professor Catherine Harmer
​​Professor of Cognitive Neuroscience ​

I am the director of the Psychopharmacology and Emotional Research Lab (PERL) based at the University Department of Psychiatry in Oxford. The research of the group focuses on the psychological mechanisms of antidepressant drug action by exploring drug effects on human models of emotional processing.

Dr Nisha Singh
​​Research Assistant ​

Neuropharmacologist with  experience in psychopharmacology, drug discovery and translational research. As part of an academic team, I have been instrumental in taking a drug from inception through to clinical evaluation in a phase II clinical trial. 

Alice Quinton
​​Research Assistant ​

Dr William Clarke
​​MRS Physicist​

I am a research assistant for the Clinical Psychopharmacology group, with an MSc in Clinical and Therapeutic Neuroscience and a broad interest in mental health research. I'm primariliy involved in conducting cognitive testing for the OxIMP research visits.  ​

I am a post-doctoral researcher working in both the physiological neuroimaging group and magnetic resonance physics groups at WIN. My work focusses on methods development of magnetic resonance spectroscopy (MRS).

Dr Marieke Martens
​​Post Doctoral Researcher​

The main focus of my role is providing support for existing and new projects within the NIHR Oxford Health BRC's Experimental Medicine theme, aimed at investigating the mechanisms of established and novel treatments for mood disorders. ​